Jörg D Leuppi
Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.
Boesing M, Abig K, Brändle M, Brutsche M, Burri E, Frye B, Giezendanner S, Grutters J, Haas P, Heisler J, Jaun F, Leuppi-Taegtmeyer A, Lüthi-Corridori G, Müller-Quernheim J, Nüesch R, Pohl W, Rassouli F, Leuppi J. Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial. Trials 2022; 23:790.
Sep 20, 2022Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.
Sep 20, 2022Trials 2022; 23:790
Boesing Maria, Abig Kristin, Brändle Michael, Brutsche Martin, Burri Emanuel, Frye BjöC, Giezendanner Stéphanie, Grutters Jan C, Haas Philippe, Heisler Justian, Jaun Fabienne, Leuppi-Taegtmeyer Anne Barbara, Lüthi-Corridori Giorgia, Müller-Quernheim Joachim, Nüesch Reto, Pohl Wolfgang, Rassouli Frank, Leuppi Jörg D
High-dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study-VitCov Trial.
Jaun F, Boesing M, Lüthi-Corridori G, Abig K, Makhdoomi A, Bloch N, Lins C, Raess A, Grillmayr V, Haas P, Schuetz P, Gabutti L, Muser J, Leuppi-Taegtmeyer A, Giezendanner S, Brändle M, Leuppi J. High-dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study-VitCov Trial. Trials 2022; 23:114.
Feb 4, 2022High-dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study-VitCov Trial.
Feb 4, 2022Trials 2022; 23:114
Jaun Fabienne, Boesing Maria, Lüthi-Corridori Giorgia, Abig Kristin, Makhdoomi Anja, Bloch Nando, Lins Christina, Raess Andrea, Grillmayr Victoria, Haas Philippe, Schuetz Philipp, Gabutti Luca, Muser Jürgen, Leuppi-Taegtmeyer Anne Barbara, Giezendanner Stéphanie, Brändle Michael, Leuppi Jörg D
Compliance of Pharmacotherapy with GOLD Guidelines: A Longitudinal Study in Patients with COPD
Grewe F, Clarenbach C, Thurnheer R, Leuppi J, Irani S, Frey M, Brutsche M, Brack T, Roeder M, Bradicich M, Sievi N, Kohler M. Compliance of Pharmacotherapy with GOLD Guidelines: A Longitudinal Study in Patients with COPD. Int J Chron Obstruct Pulmon Dis 2020; 15:627-635.
Mar 26, 2020Compliance of Pharmacotherapy with GOLD Guidelines: A Longitudinal Study in Patients with COPD
Mar 26, 2020Int J Chron Obstruct Pulmon Dis 2020; 15:627-635
Grewe Fabian A, Clarenbach Christian F, Thurnheer Robert, Leuppi Jörg D, Irani Sarosh, Frey Martin, Brutsche Martin, Brack Thomas, Roeder Maurice, Bradicich Matteo, Sievi Noriane A, Kohler Malcolm
"Can do, don't do" are not the lazy ones: a longitudinal study on physical functioning in patients with COPD
Sievi N, Brack T, Brutsche M, Frey M, Irani S, Leuppi J, Thurnheer R, Kohler M, Clarenbach C. "Can do, don't do" are not the lazy ones: a longitudinal study on physical functioning in patients with COPD. Respir Res 2020; 21:27.
Jan 20, 2020"Can do, don't do" are not the lazy ones: a longitudinal study on physical functioning in patients with COPD
Jan 20, 2020Respir Res 2020; 21:27
Sievi Noriane A, Brack Thomas, Brutsche Martin, Frey Martin, Irani Sarosh, Leuppi Jörg D, Thurnheer Robert, Kohler Malcolm, Clarenbach Christian F
Physical activity declines in COPD while exercise capacity remains stable: A longitudinal study over 5 years
Sievi N, Brack T, Brutsche M, Frey M, Irani S, Leuppi J, Thurnheer R, Kohler M, Clarenbach C. Physical activity declines in COPD while exercise capacity remains stable: A longitudinal study over 5 years. Respir Med 2018; 141:1-6.
Jun 18, 2018Physical activity declines in COPD while exercise capacity remains stable: A longitudinal study over 5 years
Jun 18, 2018Respir Med 2018; 141:1-6
Sievi Noriane A, Brack Thomas, Brutsche Martin, Frey Martin, Irani Sarosh, Leuppi Jörg D, Thurnheer Robert, Kohler Malcolm, Clarenbach Christian F
Accelerometer- versus questionnaire-based assessment of physical activity and their changes over time in patients with COPD
Sievi N, Brack T, Brutsche M, Frey M, Irani S, Leuppi J, Thurnheer R, Kohler M, Clarenbach C. Accelerometer- versus questionnaire-based assessment of physical activity and their changes over time in patients with COPD. Int J Chron Obstruct Pulmon Dis 2017; 12:1113-1118.
Apr 10, 2017Accelerometer- versus questionnaire-based assessment of physical activity and their changes over time in patients with COPD
Apr 10, 2017Int J Chron Obstruct Pulmon Dis 2017; 12:1113-1118
Sievi Noriane A, Brack Thomas, Brutsche Martin, Frey Martin, Irani Sarosh, Leuppi Jörg D, Thurnheer Robert, Kohler Malcolm, Clarenbach Christian F
Determinants of annual change in physical activity in COPD
Clarenbach C, Thurnheer R, Leuppi J, Irani S, Frey M, Brutsche M, Brack T, Haile S, Sievi N, Kohler M. Determinants of annual change in physical activity in COPD. Respirology 2017; 22:1133-1139.
Mar 30, 2017Determinants of annual change in physical activity in COPD
Mar 30, 2017Respirology 2017; 22:1133-1139
Clarenbach Christian F, Thurnheer Robert, Leuppi Jörg D, Irani Sarosh, Frey Martin, Brutsche Martin, Brack Thomas, Haile Sarah R, Sievi Noriane A, Kohler Malcolm
Impact of comorbidities on physical activity in COPD
Sievi N, Kohler M, Franzen D, Thurnheer R, Leuppi J, Irani S, Frey M, Brutsche M, Brack T, Senn O, Clarenbach C. Impact of comorbidities on physical activity in COPD. Respirology 2015; 20:413-8.
Jan 6, 2015Impact of comorbidities on physical activity in COPD
Jan 6, 2015Respirology 2015; 20:413-8
Sievi Noriane A, Kohler Malcolm, Franzen Daniel, Thurnheer Robert, Leuppi Jörg D, Irani Sarosh, Frey Martin, Brutsche Martin, Brack Thomas, Senn Oliver, Clarenbach Christian F
Accuracy of the hospital anxiety and depression scale for identifying depression in chronic obstructive pulmonary disease patients
Nowak C, Thurnheer R, Rüdiger J, Leuppi J, Irani S, Frey M, Brutsche M, Brack T, Schlatzer C, Schwarz E, Clarenbach C, Sievi N, Kohler M. Accuracy of the hospital anxiety and depression scale for identifying depression in chronic obstructive pulmonary disease patients. Pulm Med 2014; 2014:973858.
Dec 4, 2014Accuracy of the hospital anxiety and depression scale for identifying depression in chronic obstructive pulmonary disease patients
Dec 4, 2014Pulm Med 2014; 2014:973858
Nowak Christoph, Thurnheer Robert, Rüdiger Jochen, Leuppi Jörg D, Irani Sarosh, Frey Martin, Brutsche Martin, Brack Thomas, Schlatzer Christian, Schwarz Esther Irene, Clarenbach Christian F, Sievi Noriane A, Kohler Malcolm
Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial
Leuppi J, Tamm M, von Garnier C, Viatte S, Stoeckli R, Schindler C, Scherr A, Müller B, Miedinger D, Maier S, Leibbrandt Y, Henzen C, Duerring U, Drescher T, Briel M, Bodmer M, Bingisser R, Schuetz P, Rutishauser J. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA 2013; 309:2223-31.
Jun 5, 2013Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial
Jun 5, 2013JAMA 2013; 309:2223-31
Leuppi Jörg D, Tamm Michael, von Garnier Christophe, Viatte Sebastien, Stoeckli Rolf, Schindler Christian, Scherr Andreas, Müller Beat, Miedinger David, Maier Sabrina, Leibbrandt Yolanda, Henzen Christoph, Duerring Ursula, Drescher Tilman, Briel Matthias, Bodmer Michael, Bingisser Roland, Schuetz Philipp, Rutishauser Jonas
Combined oximetry-cutaneous capnography in patients assessed for long-term oxygen therapy
Schafroth Török S, Leuppi J, Baty F, Tamm M, Chhajed P. Combined oximetry-cutaneous capnography in patients assessed for long-term oxygen therapy. Chest 2008; 133:1421-5.
Jun 1, 2008Combined oximetry-cutaneous capnography in patients assessed for long-term oxygen therapy
Jun 1, 2008Chest 2008; 133:1421-5
Schafroth Török Salome, Leuppi Jörg D, Baty Florent, Tamm Michael, Chhajed Prashant N
Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept
Leuppi J, Chan H, Greiff L, Andersson M, Knoblauch A, Surber C, Perruchoud A, Bingisser R, Brutsche M, Stolz D, Anderson S, Tandjung R, Tamm M. Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept. Pulmonary pharmacology & therapeutics 2005; 18:83-8.
Jan 1, 2005Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept
Jan 1, 2005Pulmonary pharmacology & therapeutics 2005; 18:83-8
Leuppi Jörg D, Chan Hak-Kim, Greiff Lennart, Andersson Morgan, Knoblauch Andreas, Surber Christian, Perruchoud André P, Bingisser Roland, Brutsche Martin, Stolz Daiana, Anderson Sandra D, Tandjung Ryan, Tamm Michael
An individualized, adjustable maintenance regimen of budesonide/formoterol provides effective asthma symptom control at a lower overall dose than fixed dosing
Leuppi J, Salzberg M, Meyer L, Bucher S, Nief M, Brutsche M, Tamm M. An individualized, adjustable maintenance regimen of budesonide/formoterol provides effective asthma symptom control at a lower overall dose than fixed dosing. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:302-9.
May 31, 2003An individualized, adjustable maintenance regimen of budesonide/formoterol provides effective asthma symptom control at a lower overall dose than fixed dosing
May 31, 2003Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:302-9
Leuppi Jörg D, Salzberg Marc, Meyer L, Bucher S E, Nief M, Brutsche Martin, Tamm Michael